Lastly, thanks to the free carboxylic groups in the polymer backbone, HA-based NPs can be further chemically conjugated with an aptamer or other specific ligands in order to obtain dual/multi-targeted NPs which can increase selectivity and efficacy against CD44+ cancer cells [18,19]. This evidence concerns the gene CD44 and cancer.